"Tumor Virus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses.
| Descriptor ID |
D014412
|
| MeSH Number(s) |
C02.928
|
| Concept/Terms |
Tumor Virus Infections- Tumor Virus Infections
- Infections, Tumor Virus
- Infection, Tumor Virus
- Tumor Virus Infection
|
Below are MeSH descriptors whose meaning is more general than "Tumor Virus Infections".
Below are MeSH descriptors whose meaning is more specific than "Tumor Virus Infections".
This graph shows the total number of publications written about "Tumor Virus Infections" by people in this website by year, and whether "Tumor Virus Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 0 | 3 |
| 1997 | 3 | 0 | 3 |
| 1998 | 4 | 1 | 5 |
| 1999 | 4 | 1 | 5 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 3 | 0 | 3 |
| 2003 | 3 | 2 | 5 |
| 2004 | 3 | 1 | 4 |
| 2005 | 5 | 0 | 5 |
| 2006 | 2 | 0 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 3 | 1 | 4 |
| 2009 | 1 | 1 | 2 |
| 2010 | 4 | 1 | 5 |
| 2011 | 0 | 1 | 1 |
| 2012 | 3 | 2 | 5 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 3 | 1 | 4 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tumor Virus Infections" by people in Profiles.
-
A novel histologic index for polyomavirus nephropathy in comparison with the Banff scoring system: Clinical validation, prognostic implication, and correlation with plasma viral load. Ann Diagn Pathol. 2025 Apr; 75:152430.
-
BK Virus Epidemiology, Risk Factors, and Clinical Outcomes: An Analysis of Hematopoietic Stem Cell Transplant Patients at Texas Children's Hospital. J Pediatric Infect Dis Soc. 2021 Apr 30; 10(4):492-501.
-
Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double-blind, randomized, placebo-controlled trial. Am J Transplant. 2019 06; 19(6):1831-1837.
-
Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia. Clin Transplant. 2018 06; 32(6):e13265.
-
Intravesicular cidofovir for BK hemorrhagic cystitis in pediatric patients after hematopoietic stem cell transplant. Pediatr Transplant. 2018 05; 22(3):e13141.
-
Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients. Clin Transpl. 2016; 32:103-109.
-
Viral microRNA effects on pathogenesis of polyomavirus SV40 infections in syrian golden hamsters. PLoS Pathog. 2014 Feb; 10(2):e1003912.
-
Characterization of mammary cancer stem cells in the MMTV-PyMT mouse model. Tumour Biol. 2012 Dec; 33(6):1983-96.
-
Tumor-derived mesenchymal stem cells and orthotopic site increase the tumor initiation potential of putative mouse mammary cancer stem cells derived from MMTV-PyMT mice. Tumour Biol. 2012 Dec; 33(6):1997-2005.
-
Patterns of polyomavirus SV40 infections and associated cancers in humans: a model. Curr Opin Virol. 2012 Aug; 2(4):508-14.